The purpose of the study is to compare two fixed dose combination tablets of dapagliflozin/metformin XR in healthy subjects under fasting and fed conditions

Trial Identifier:	D1691C00016
Sponsor:	AstraZeneca
NCTID::	NCT03216278
Start Date:	September 2017
Primary Completion Date:	May 2018

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Portugese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil	Aparecida de Goiania, Brazil, 74935-530

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.